1 Department of Health, Nursing, Administration, Hochschule Neubrandenburg , Neubrandenburg, Germany .
2 Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina , Columbia, South Carolina.
AIDS Patient Care STDS. 2018 Sep;32(9):340-348. doi: 10.1089/apc.2018.0099.
As the number of effective antiretroviral therapy (ART) options increases, there is greater opportunity to involve HIV patients in ART selection. To establish the parameters for a shared ART decision-making process, we sought to identify ART characteristics that are important to patients and understand considerations in ART selection from both patient and provider perspectives. Using a mixed-methods approach, 16 patients and 12 healthcare providers were interviewed, and ranking tasks were conducted with 26 patients to identify ART characteristics that are relevant for shared decision making. Interviews were coded using direct content analysis and complemented by a quantitative analysis of references to specific attributes. Ranking data were analyzed through count analysis. Qualitative analysis of patient interviews identified four major categories of ART characteristics that are pertinent to shared decision making: side effects (14/16 patients), administration characteristics (14/16 patients), dosing (13/16 patients), and long-term effects (12/16 patients). Other considerations included expectations for patient involvement in ART decision making, relationship with provider, and efficacy. The degree of concordance between patients and providers differed across categories. Ranking exercises demonstrated differences in the ways providers and patients prioritize specific side effects and food requirements. Expectations for patient involvement in the selection process also varied greatly among and between patients and providers. We identify specific attributes of ART that are decision-relevant to patients and providers, describe heterogeneity of their relative importance, and note variable perceptions of shared decision making. Individualizing ART will require greater investment in understanding an individual patient's preferences, including her/his desire to participate in shared decision making.
随着有效的抗逆转录病毒疗法 (ART) 选择的增加,患者有更多机会参与 ART 选择。为了建立共享 ART 决策过程的参数,我们试图确定对患者重要的 ART 特征,并从患者和提供者的角度了解 ART 选择中的考虑因素。我们采用混合方法,对 16 名患者和 12 名医疗保健提供者进行了访谈,并对 26 名患者进行了排序任务,以确定与共享决策相关的 ART 特征。使用直接内容分析对访谈进行编码,并辅以对特定属性的定量分析。通过计数分析对排名数据进行分析。对患者访谈的定性分析确定了与共享决策相关的四个主要的 ART 特征类别:副作用(16 名患者中有 14 名)、管理特点(16 名患者中有 14 名)、剂量(16 名患者中有 13 名)和长期影响(16 名患者中有 12 名)。其他考虑因素包括对患者参与 ART 决策的期望、与提供者的关系和疗效。患者和提供者之间对这些类别的一致性存在差异。排名练习表明,提供者和患者在优先考虑特定副作用和饮食需求方面存在差异。对患者参与选择过程的期望在患者和提供者之间也存在很大差异。我们确定了对患者和提供者有决策意义的 ART 特定属性,描述了它们相对重要性的异质性,并注意到共享决策的看法存在差异。个体化 ART 将需要更多地投资于了解患者的个人偏好,包括她/他参与共享决策的愿望。